We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Effects of Early Nutrition on Growth

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01300000
First Posted: February 21, 2011
Last Update Posted: March 29, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Institute of Child Health
Information provided by (Responsible Party):
Abbott Nutrition
  Purpose
The primary objective of the study is to compare the growth of infants fed standard infant formula with infants fed a reduced calorie and protein formula.

Condition Intervention
Infant Newborn Other: Human Milk Other: Investigational infant formula Other: Milk based standard infant formula

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Effects of Early Nutrient Intake on Growth and Body Composition

Resource links provided by NLM:


Further study details as provided by Abbott Nutrition:

Primary Outcome Measures:
  • Weight gain [ Time Frame: 1- 365 days ]

Secondary Outcome Measures:
  • Gastrointestinal tolerance [ Time Frame: 1-365 days ]
  • Infant Anthropometrics [ Time Frame: 1 - 365 days; 24 months ]

Other Outcome Measures:
  • Vascular [ Time Frame: at 24 months ]
  • Maternal Anthropometrics [ Time Frame: at 24 months ]

Enrollment: 649
Actual Study Start Date: March 2010
Study Completion Date: August 2016
Primary Completion Date: September 2014 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: Human Milk
ad lib
Other: Human Milk
ad lib
Active Comparator: Milk based standard infant formula
ad lib
Other: Milk based standard infant formula
ad lib
Experimental: Milk based investigational infant formula
ad lib
Other: Investigational infant formula
ad lib

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   up to 24 Hours   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • good health
  • singleton birth with gestational age 37-42 weeks
  • infant's birth weight >or = to 2500 grams
  • exclusive breastfeeding or exclusively formula feeding
  • within a defined geographical boundary
  • mother has no problems communicating in English

Exclusion Criteria:

  • adverse maternal, fetal or infant medical history
  • congenital disease or malformation affecting growth or development
  • illness or social problems in mother or infant
  • temporary residents
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01300000


Locations
United Kingdom
MRC Childhood Nutrition Research Center, Institute of Child Health
London, United Kingdom
Sponsors and Collaborators
Abbott Nutrition
Institute of Child Health
Investigators
Study Chair: Barbara Marriage, PhD Abbott Nutrition
  More Information

Responsible Party: Abbott Nutrition
ClinicalTrials.gov Identifier: NCT01300000     History of Changes
Other Study ID Numbers: AK65
First Submitted: February 17, 2011
First Posted: February 21, 2011
Last Update Posted: March 29, 2017
Last Verified: March 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided